Insider · CIK 0001114916
VENKATARAMAN BALAJI
Reports to the SEC for 6 companies · ALPHARETTA, GA
Transactions
5
Companies
6
Filings
3
CIK
0001114916
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-09-24 | JSPRJasper Therapeutics, Inc.M Exercise/Conversion | — |
| 2021-09-24 | JSPRJasper Therapeutics, Inc. · Class B Common StockD Disposition to Issuer | — |
| 2021-09-24 | JSPRJasper Therapeutics, Inc. · Class B Common StockM Exercise/Conversion | — |
| 2020-01-03 | JSPRJasper Therapeutics, Inc. · Class B Common StockJ Other | — |
| 2014-11-13 | Horizon Therapeutics Public Ltd CoS Sale | −$70.2M |
Recent filings
- 4VENKATARAMAN BALAJI0001213900-21-050329SEC(opens sec.gov)
- 4VENKATARAMAN BALAJI0001213900-20-000421SEC(opens sec.gov)
- 4Horizon Pharma plc0001209191-14-069261SEC(opens sec.gov)
Companies
- ALIMERA SCIENCES INC10% Owner
- HERON THERAPEUTICS, INC. /DE/See Footnote 2HRTX
- Horizon Therapeutics Public Ltd CoFormer 10% Owner
- Jasper Therapeutics, Inc.10% OwnerJSPR
- PROGENICS PHARMACEUTICALS INC10% Owner, See Explanation of Responses
- SCIELE PHARMA, INC.Executive Vice President and Chief Operating Officer
Address
13185 OWENS WAY
ALPHARETTA, GA, 30004